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Quercetin, a flavonoid, is found in many plants, including edible fruits and vegetables. We examined the effects on cell growth of human malignant 
cells derived from the gastrointestinal tract and on cell cycle progression. Quercetin markedly inhibited the growth of human gastric cancer cells 
and the ICsO value was 32-55 PM. DNA synthesis was suppressed to 14% of the control level by the treatment with 70 PM quercetin for 2 days. 
Furthermore, quercetin blocked cell progression from the Gi to the S phase. 
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1, INTRODUCTION 
Quercetin, a flavonoid found in many plants, is wide- 
ly distributed in edible fruits and vegetables. Humans 
regularly consume foods containing quercetin not only 
in its free form, but also in the fi-glycoside form, such 
as rutin and quercitrin. When quercetin was adminis- 
tered orally, it was poorly absorbed from the digestive 
tract and did not have a great influence on the organs 
except the gastrointestinal tract. A proportion of the 
quercetin administered was degraded by the intestinal 
microflora and the remainder was excreted in feces in 
an unchanged form [l-2]. 
Recently quercetin was found to inhibit the cell 
growth of leukemia cells, Ehrich ascites tumor cells [3], 
and NK/Ly ascites tumor cells 141. To clarify the mech- 
anism of anti-tumor effects, we examined its effect on 
the cell growth of four human gastric cancer cell lines, 
as well as on the cell cycle. 
2. MATERIALS AND METHODS 
2.1. Cell line and chemicals 
Quercetin was purchased from Wako Pure Chemical Industries, 
Osaka. In this study, four human gastric cancer cell lines, HGC-27 
[S], NUGC-2 [6], MKN-7, and MKN-28 [7] were used. Ceils were cul- 
tured in RPM1 1640 (Nissui) supplemented with 10% fetal calf serum 
and incubated at 37°C in a humidifi~ atmosphere containing 5% 
COz. Quercetin was dissolved in 0.25% dimethy sulfoxide (DMSO) 
and diluted to its final concentration in each culture dish. 
2.2. Measurement of cytotoxicity 
Cells were plated at a density of 4 x 104 cells/2 ml medium in 
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35 mm diameter dishes. The various concentrations of quercetin were 
added at the inoculation of cells, or at the 2nd day after the inocula- 
tion of cells. Control cells were exposed to DMSO at the same concen- 
tration as the other dishes. The culture was continued without 
medium change. The number of viable cells were measured by the 
Trypan blue dye exclusion test. The values represent means * SD. 
Data were analyzed using a two-tailed Student’s t-test. 
2.3. Me~urement of DNA synthesis 
. DNA synthesis was assayed at 1, 3, 12, 18, 24, 36, and 48 h after 
treatment with quercetin. HGC-27 cells were incubated for 1 h with 
10,&i of [‘H]thymidine. The cells were washed with 2 ml of 
phosphate-buffered saline, treated with 2 ml of 5% trichloroacetic 
acid (TCA), and kept overnight or longer in a wet chamber. Cells were 
washed with 2 ml of 5% TCA and solubilized with 0.8 ml of 1% 
sodium dodecyl sulphate. The radioactivities of aliquots were counted 
in a liquid scintillation spectrometer. Data were converted to dpm per 
pg cellular protein. 
Protein concentrations were determined by a modification of the 
method of Lowry et al. [S]. The results were expressed as percent in- 
hibition, compared with the result of the control experiment in which 
quercetin was absent. 
2.4. Analysis of ceil cycle progression 
Cells were plated at a density of 1 x lo5 cells/5 ml medium in 
55 mm diameter dishes. Quercetin at a concentration of 70 FM was 
added after 2 days. In the preliminary data we found that the effect 
of quercetin on the cell growth diminished with time. Thus, the 
medium with quercetin was changed every 8 h for 24 h (see fig.3, 
l-3). After this incubation, the cells were transferred to the medium 
without quercetin in some experiments, in order to analyze in which 
phase quercetin has an effect (see fig.3,4-9). In order to synchronize 
cells to the Gi phase, cells were plated at a density of 1 x 10’ cells/ 
55 mm diameter dish and cultured in the above medium containing 
10% FCS for 24 h. The cells were then washed once with PBS and in- 
cubated in the same medium containing 0.5% FCS for 72 h. After this 
incubation, more than 90% of the cells were in the Gi phase. The cells 
were then transferred to the medium containing 10% FCS to initiate 
progression of the cell cycle. One group of cells was incubated in the 
above medium without quercetin (see fig.4, AI-AS) and the other 
group was incubated in the above medium with 70pM quercetin to 
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analyze the effect of quercetin on the cells in the Gr phase (see fig.4, 
Br-Bs). The G-enriched cells by serum starvation shifted to the S 
phase and the Gz/M phase as a synchronized cell population in the 
medium containing 10% FCS for 19 h. These S- and Gz/M-enriched 
cells were incubated in the above medium with 30pM quercetin to 
analyze the effect of quercetin on the cells in the S phase and the 
Gz/M phase (see fig.5). 
2.5. Flow cytometric analysis 
Cells were removed from culture plates by brief trypsinization and 
were spun down at 750 rpm for 5 min. After the cell pellets were 
washed with 3 ml of ice-cold Tris buffer (1.2% Tris, 0.6% NaCl, pH 
7.6), they were suspended in 1 ml of ice-cold 0.1% Triton X-100 in 
0.3 M NaWO.01 M glycine and 0.2 ml of 1% RNase solution was 
added. The DNA of these cells was stained with 0.1 ml of ethidium 
bromide solution (0.2 mg/ml). The DNA content was analyzed by us- 
ing a flow cytometer FACStar (Becton Dickinson Fats System). 
3. RESULTS 
3.1. Effect on progression of the human gastric cancer 
cells 
Fig.1 shows the growth curve of HGC-27 cells in the 
presence of various concentrations of quercetin. A 
dose-dependent inhibition of growth was observed over 
10pM (3.4pg/ml). At 48 h after the addition of 
quercetin, the growth of the cells decreased to about 
70%, 23%, and 10% of the control level by the treat- 
ment with 10, 30, and 70 PM of quercetin, respectively. 
Cell numbers were gradually reduced to below the level 
of the inoculum at quercetin concentrations of over 
70 ,uM. IC~O values of four human gastric cell lines were 
32-55 ,uM. HGC-27 cells, which we used mainly in this 
study, and NUGC-2 are poorly differentiated adenocar- 
cinema cells, and the other two cell lines, MKN-28 and 
MKN-7 cells, are well-differentiated adenocarcinoma 
cells. There was no difference in the sensitivity to 
quercetin among these types of cells (table 1). 
3.2. Effect on DNA synthesis 
Quercetin suppressed DNA synthesis in a dose- 
dependent manner. DNA synthesis was suppressed to 
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Fig.1. Effect of quercetin on the growth of HGC-27 cells. Various Fig.2. Effect of quercetin on DNA synthesis in HGC-27 cells. Various 
concentrations of quercetin were added on the 2nd day after inocula- concentrations of quercetin were added on the 2nd day after the in- 
tion of cells. The values represent means + SD. The arrow indicates oculation of cells. After 1, 3, 12, l&24,36,48 h, DNA synthesis was 
when quercetin was added. assayed as described in section 2. The values represent means f SD. 
Table 1 
Effect of quercetin on the proliferation of four gastric cancer cell lines 
Cell line ICso 01M) 
HGC-27 52 
NUGC-2 32 
MKN-28 35 
MKN-7 55 
Various concentrations of quercetin were added simultaneously at the 
inoculation of cells. The culture was continued for 4 days. The ICSO 
of each cell line was calculated 
about 64%,48%, and 14% of the control level with 10, 
30, and 70 PM quercetin, respectively, at 12-18 h after 
the addition of quercetin. Suppression of DNA syn- 
thesis was observed as early as 1 h after addition of 
quercetin. With 10 ,uM of quercetin, DNA synthesis 
began to increase after 12 h and recovered to about 
90% of the control level at 48 h. With 30 and 70 PM of 
quercetin, DNA synthesis began to increase after 
18-24 h (fig.2). 
3.3. Effect on cell cycle progression 
As shown in fig.3, during the first 24 h, the cyto- 
kinetic alterations induced by quercetin were character- 
ized by marked Gz/M phase evacuation and S phase re- 
duction. After removal of quercetin, cells moved 
through the S, Gz, and M phase as a synchronized cell 
population. These results suggest hat quercetin arrests 
these cells at the GI or early S phase. As shown in fig.4, 
serum starvation resulted in enrichment of HGC-27 
cells in the Gr phase of the cell cycle. When these cells 
were supplemented with 10% FCS, progression into the 
cell cycle was initiated. Cells in the GI phase decreased 
and cells in the S phase gradually increased during 
16-20 h. At 20 h, the proportion of cells in the S phase 
markedly increased. Many cells shifted to the Gz/M 
phase during 20-24 h and accumulated again in the Gr 
phase at 36 h (fig.4, AI-A5). 
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Fig.3. DNA histograms of HGC-27 cells. Cells were plated at a densi- 
ty of 1 x 16 celtsldish and cultured in media containing 70 /cM of 
quercetin. The medium with 70pM of quercetin was changed every 8 
h (l-3). After this incubation, cells were transferred to the medium 
without quercetin (4-8). 
When 70pM of quercetin was added to the 
Gl-enriched cells, it inhibited progression of the cells in- 
to the S phase for 24 h (fig.4, Bl-Be). After 36-48 h, 
the cells began to progress into the S phase (fig.4, Bs). 
This progression was delayed for 20 h compared to the 
control cases. 
When 30 PM of quercetin was added to the S- and 
Gz/M-enriched cells, it did not inhibit progression of 
the cells into the Gz/M phase and the G1 phase (fig.5). 
Cells in the S phase and the G2/M phase decreased and 
the proportion of cells in the Gl phase gradually in- 
creased. However, cells in the Gl phase were not found 
to shift to the S phase. 
4. DISCUSSION 
Various biochemical effects of quercetin have been 
shown in numerous studies. Regarding its mutagenicity, 
quercetin was shown to exhibit mutagenic activity in 
both bacterial [9-l l] and mammalian cell systems 
[ 12-141. Although some mutagens show carcinogenic 
activity and their effects overlap with some car- 
cinogens, mutagenicity has been proven to not 
necessarily be related to carcinogenicity. In fact, the 
carcinogenicity of quercetin has been extensively 
studied, but could not be confirmed [15-20], with one 
exception [21]. Nishino et al. [22] and Kato et al. [23] 
showed that quercetin inhibited the ceil growth- 
promoting effect of teleocidin or 12-O-tetra- 
decanoylphorbol-l3-acetate on skin papiiloma forma- 
tion in mice. These results indicate that quercetin is not 
carcinogenic despite its mutagenicity. 
Quercetin was shown to inhibit the synthesis of 
DNA, RNA, and protein in Ehrich ascites tumor cells 
[24]. This is in agreement with our results which showed 
that quercetin markedly decreases the synthesis of 
DNA. The time course of change in DNA synthesis in 
gastric cancer cells treated with quercetin was found to 
correlate well with that of the decrease of the S phase 
population by flow cytometric analysis (fig.3). 
It is thought that in the cell cycle phases, the Gl phase 
is the major site for the control of animal cell prolifera- 
tion and the major difference between normal cells and 
malignant tumor cells depends on the GI phase. We 
demonstrated that quercetin induced a specific Gl ar- 
rest in human gastric cancer cells. 
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Fig.4. DNA histograms of HGC-27 cells after serum starvation. To 
synchronize cells to the G, phase, cells were incubated in the same 
medium containing O.Wo FCS for 72 h (0 h). The control group of 
cells was transferred to the medium containing 10% FCS to initiate 
progression (Al-As). The other group of cells was transferred to the 
medium containing 10% FCS and 70 FM quercetin (BI-B5). 
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Fig.5. DNA histograms of HOC-27 cells after serum starvation. To 
synchronize cells in the S phase and the Gz/M phase, cells were in- 
cubated in the same medium containing 10% FCS for 19 h after serum 
starvation (1). These cells were transferred to the medium with 30/tM 
quercetin added (2-4). 
Most cells were apparently arrested at the end of the 
Gr phase by the treatment with quercetin, and after 
removal of quercetin, moved through the subsequent S, 
Gz, and M phases as a synchronized cell population. 
The results of our experiments on short time exposure 
to quercetin demonstrated that quercetin-induced cell 
cycle arrest was reversed by the cell wash. Since, in these 
studies, however, exponentially growing cells were used 
for the analysis, the precise properties of quercetin- 
induced cell arrest have not been characterized. We 
therefore synchronized the growth of HGC-27 cells by 
serum starvation, and analyzed the effects of quercetin 
on these cells (figs 4,5). The results indicate that 
quercetin had no effect on the cell cycle progression in 
the S phase and the &/M phase, and the growth in- 
hibitory effect of quercetin was the result of the arrest 
in the Gr phase of the cell cycle. 
Human beings are exposed to quercetin continuously 
and it has been estimated that the average person is ex- 
posed to about 50 mg ‘quercetin equivalents’ per day 
[25]. This suggests that it is a potent anticancer agent in 
man. In addition, the frequent intake of fruits and 
vegetables which contain quercetin may be a successful 
cancer preventive measure. Quercetin may be important 
from the point of view of the epidemiology concerning 
malignant tumors of the gastrointestinal tract. 
Although we found that quercetin induces a specific 
Gi arrest in the human gastric cancer cell, the biochem- 
ical mechanism of this Gr block is not yet known. Fur- 
ther investigation to clarify the mechanism of the cyto- 
toxic action of quercetin and the regulating mechanism 
of the cell cycle progression by using quercetin, is now 
in progress. 
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